Question 1

What is Saxagliptin?

Accepted Answer

Saxagliptin works by increasing the levels of natural substances called incretins. These substances help the pancreas release more insulin when blood sugar is high and signal the liver to produce less sugar.

By improving how the body handles insulin and sugar, this medication helps maintain more stable blood glucose levels throughout the day.

Question 2

What is Saxagliptin used for?

Accepted Answer

Saxagliptin is used to treat type 2 diabetes mellitus .

Question 3

How does Saxagliptin work?

Accepted Answer

How Saxagliptin Works

Saxagliptin belongs to a class of medications known as dipeptidyl peptidase-4 (DPP-4) inhibitors. It works by blocking the action of the DPP-4 enzyme, which normally breaks down hormones in the body called incretins.

Incretin hormones are released by the intestines throughout the day, and their levels increase significantly after a meal. These hormones help the body manage blood sugar in two main ways:

Stimulating Insulin Release: Incretins signal the pancreas to produce and release more insulin when blood sugar levels are high. Insulin is the hormone responsible for moving sugar from the blood into the cells to be used for energy.

Decreasing Sugar Production: Incretins reduce the amount of glucagon released by the pancreas. Glucagon is a hormone that signals the liver to produce more sugar. By lowering glucagon levels, saxagliptin helps prevent the liver from making excess sugar.

By inhibiting the DPP-4 enzyme, saxagliptin allows these incretin hormones to stay active in the body for a longer period. This helps the body better regulate blood sugar levels, particularly after eating. Because the medication primarily works when blood sugar is high, it has a lower risk of causing blood sugar to drop too low ( hypoglycemia ) when used as a single therapy compared to some other types of diabetes medications.

Question 4

What are the brand names for Saxagliptin?

Accepted Answer

Saxagliptin is sold under the brand name Onglyza .

Question 5

What are the active ingredients in Saxagliptin?

Accepted Answer

The active ingredient in Saxagliptin is saxagliptin .

Question 6

What are the side effects of Saxagliptin?

Accepted Answer

Common side effects of Saxagliptin may include:

upper respiratory tract infection

headache

Always consult with a healthcare professional about potential side effects.

Question 7

What drug class is Saxagliptin?

Accepted Answer

Saxagliptin belongs to the DPP-4 inhibitor drug class.

Question 8

What is the dosage of Saxagliptin and how do I take it?

Accepted Answer

How to Take Saxagliptin

Saxagliptin comes as a tablet to be taken by mouth. It is generally taken once a day and can be consumed with or without food. It is important to take this medication at the same time each day to maintain consistent levels in the body.

When taking this medication, follow these guidelines:

Swallow the tablets whole. Do not crush, chew, or break the tablets.

Continue to follow the diet and exercise program recommended by your healthcare provider while taking this medication.

Check your blood sugar regularly as directed by your doctor.

Missed Dose

If you miss a dose of saxagliptin, take it as soon as you remember. However, if it is nearly time for your next scheduled dose, skip the missed dose and continue with your regular dosing schedule. Do not take a double dose to make up for a missed one.

Question 9

Is Saxagliptin safe during pregnancy and breastfeeding?

Accepted Answer

Pregnancy

Data regarding the use of saxagliptin in pregnant women are limited. While animal studies have not shown a high risk of birth defects or developmental issues at standard doses, there are no adequate and well-controlled studies in humans. Because human data are insufficient to inform a drug-associated risk, the medication should be used during pregnancy only if clearly needed.

Maintaining stable blood sugar levels is critical during pregnancy to prevent complications for both the parent and the baby. Healthcare providers often recommend alternative treatments, such as insulin, to manage diabetes during this time because those treatments have more established safety profiles for pregnancy.

Breastfeeding

It is currently unknown whether saxagliptin passes into human breast milk. Because many drugs are excreted in milk and the potential for adverse effects on a nursing infant is not fully understood, caution should be exercised. Patients should discuss the risks and benefits of continuing or stopping the medication while breastfeeding with their healthcare provider to determine the best course of action.

Question 10

What forms and strengths does Saxagliptin come in?

Accepted Answer

Available Forms

Saxagliptin is currently available in the following form:

Oral film-coated tablet

This medication is also available in combination with other medications used to treat type 2 diabetes, such as metformin or dapagliflozin , which are also provided in oral tablet forms.

Question 11

What is the FDA approval status of Saxagliptin?

Accepted Answer

FDA Approval and Indications

Saxagliptin was approved by the U.S. Food and Drug Administration (FDA) as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus. It belongs to a class of medications known as dipeptidyl peptidase-4 (DPP-4) inhibitors. It is not indicated for the treatment of type 1 diabetes or diabetic ketoacidosis.

Safety Communications

In 2016, the FDA issued a safety communication requiring the addition of new warnings to the drug label regarding an increased risk of heart failure. This risk was identified primarily in patients who already had heart or kidney disease. The FDA recommends that healthcare professionals consider discontinuing saxagliptin in patients who develop heart failure and monitor for signs and symptoms of the condition.

Regulatory Warnings and Precautions

The FDA-approved labeling for saxagliptin includes several important safety warnings:

Heart Failure: Clinical trials observed an increased rate of hospitalization for heart failure in patients treated with saxagliptin.

Pancreatitis: There have been postmarketing reports of acute pancreatitis. Patients should be monitored for persistent, severe abdominal pain.

Severe Joint Pain: The FDA has warned that DPP-4 inhibitors may cause severe and disabling joint pain, which may occur at any time during treatment.

Bullous Pemphigoid: Postmarketing cases of bullous pemphigoid requiring hospitalization have been reported with DPP-4 inhibitor use.

Renal Impairment: Because saxagliptin is partially cleared by the kidneys, the FDA-approved labeling includes specific dosage adjustment recommendations for patients with moderate to severe renal impairment.

Question 12

What should I know about Saxagliptin and fda?

Accepted Answer

FDA Indications

The FDA has approved saxagliptin as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus. It is not indicated for the treatment of type 1 diabetes or diabetic ketoacidosis.

FDA Safety Communications

The FDA has issued specific warnings regarding the use of saxagliptin, including an increased risk of heart failure, particularly in patients who already have heart or kidney disease. Patients should be monitored for signs and symptoms of heart failure, such as shortness of breath, tiredness, or swelling in the ankles and feet.

Additional FDA safety concerns associated with saxagliptin include:

Pancreatitis: Cases of acute pancreatitis have been reported. The medication should be discontinued if pancreatitis is suspected.

Severe Joint Pain: The FDA has warned that DPP-4 inhibitors may cause severe and disabling joint pain.

Bullous Pemphigoid: There have been reports of serious skin reactions that may require medical intervention.

Hypoglycemia: When used with other diabetes medications like insulin or sulfonylureas, the risk of low blood sugar increases.

Saxagliptin

Medication Quick Facts

📋Overview

What It's Used For

How It Works

Brand Names

Side Effects

Warnings & Precautions

Dosage & How to Take

Pregnancy & Breastfeeding

Forms & Strengths

FDA / Regulatory Status

Fda Information

FAQ

Found an Error?